SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

MitoCareX Bio Completes Initial Computational Drug Screening Stage

MitoCareX Bio says it completed the initial computational screening stage of its AI-driven drug discovery initiative with Boltz.

NXTS

Related stories